Posts - Bill - HR 3676 Executive Order 14293 Act of 2025
house 06/03/2025 - 119th Congress
We are working to make regulatory changes permanent that encourage the production of essential medicines here at home, aiming to strengthen our supply chain and ensure better access for everyone.
Congress.gov
HR 3676 - Executive Order 14293 Act of 2025
Views
right-leaning 06/03/2025
Less red tape means America making the meds we need here, not relying on the whims of foreign factories—finally, some common sense!
left-leaning 06/03/2025
Cutting regulations on critical meds is like handing corporations a fast pass to cut corners—health can’t be sacrificed for profit.
right-leaning 06/03/2025
Cutting regulations isn’t just smart; it’s patriotic. Let’s get our critical medicine supply chain under American control.
moderate 06/03/2025
Striking a balance between speed and safety isn’t simple, but we can't afford to bottleneck life-saving meds either.
left-leaning 06/03/2025
If we’re serious about healthcare, let’s invest in robust oversight instead of loosening the reins on Big Pharma’s playground.
left-leaning 06/03/2025
Promises of ‘domestic production’ ring hollow when it’s deregulation dressed up as progress—patients deserve safety, not shortcuts.
moderate 06/03/2025
Turning an executive order into law: bold move or just bureaucracy in disguise? Time will tell if this helps or hinders.
right-leaning 06/03/2025
Why wait for slow government when we can empower domestic producers to deliver lifesaving drugs faster and cheaper?
moderate 06/03/2025
Regulatory relief could be a win if it genuinely speeds production without throwing caution out the window—let’s watch this closely.